Barnet Dulaney Perkins Eye Center | |
10195 N Oracle Rd, Ste 125, Oro Valley, Arizona 85704 | |
(520) 955-1000 |
Name | Barnet Dulaney Perkins Eye Center |
---|---|
Organization Name | Barnet Dulaney Perkins Eye Center Ii Pllc |
Location | 10195 N Oracle Rd, Ste 125, Oro Valley, Arizona 85704 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (520) 955-1000 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
BioCision, LLC, a leader in advanced technology to improve biological sample handling and standardization, today announced that it will collaborate with Celgene Cellular Therapeutics (CCT) (a subsidiary of Celgene Corporation), to accelerate the development of a cell thawing solution based on BioCision's proprietary ThawSTARĂ” technology for the 6 mL injectable vial that CCT has chosen to store PDA-002, a cryopreserved, allogeneic cell therapy currently in clinical development to treat diabetic foot ulcers in patients with peripheral arterial disease.
It does not take an infinite number of monkeys to type a passage of Shakespeare. Instead, it takes a single monkey equipped with brain-sensing technology - and a cheat sheet.
A new study shows that young adults often use e-cigarettes without being aware of what is in them or which brand they are using. The study, published online in March 2020 in the Journal of Adolescent Health, raises concerns about the labeling and regulation of vaping products.
Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R&D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash.
Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these microbes. The study titled, "The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study," was published in the latest issue of the journal Therapeutics and Prevention.
› Verified 8 days ago
NPI Number | 1619468063 |
Organization Name | BARNET DULANEY PERKINS EYE CENTER, PC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 10195 N Oracle Rd Ste 125, Oro Valley, AZ 85704 |
Phone Number | 520-955-1000 |
News Archive
BioCision, LLC, a leader in advanced technology to improve biological sample handling and standardization, today announced that it will collaborate with Celgene Cellular Therapeutics (CCT) (a subsidiary of Celgene Corporation), to accelerate the development of a cell thawing solution based on BioCision's proprietary ThawSTARĂ” technology for the 6 mL injectable vial that CCT has chosen to store PDA-002, a cryopreserved, allogeneic cell therapy currently in clinical development to treat diabetic foot ulcers in patients with peripheral arterial disease.
It does not take an infinite number of monkeys to type a passage of Shakespeare. Instead, it takes a single monkey equipped with brain-sensing technology - and a cheat sheet.
A new study shows that young adults often use e-cigarettes without being aware of what is in them or which brand they are using. The study, published online in March 2020 in the Journal of Adolescent Health, raises concerns about the labeling and regulation of vaping products.
Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R&D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash.
Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these microbes. The study titled, "The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study," was published in the latest issue of the journal Therapeutics and Prevention.
› Verified 8 days ago
News Archive
BioCision, LLC, a leader in advanced technology to improve biological sample handling and standardization, today announced that it will collaborate with Celgene Cellular Therapeutics (CCT) (a subsidiary of Celgene Corporation), to accelerate the development of a cell thawing solution based on BioCision's proprietary ThawSTARĂ” technology for the 6 mL injectable vial that CCT has chosen to store PDA-002, a cryopreserved, allogeneic cell therapy currently in clinical development to treat diabetic foot ulcers in patients with peripheral arterial disease.
It does not take an infinite number of monkeys to type a passage of Shakespeare. Instead, it takes a single monkey equipped with brain-sensing technology - and a cheat sheet.
A new study shows that young adults often use e-cigarettes without being aware of what is in them or which brand they are using. The study, published online in March 2020 in the Journal of Adolescent Health, raises concerns about the labeling and regulation of vaping products.
Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R&D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash.
Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these microbes. The study titled, "The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study," was published in the latest issue of the journal Therapeutics and Prevention.
› Verified 8 days ago
Cvs Pharmacy #10006 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10650 N Oracle Rd, Oro Valley, Arizona 85737 Phone: (520) 544-5544 | |
Cvs Pharmacy #16217 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10555 N Oracle Rd, Oro Valley, Arizona 85737 Phone: (520) 219-4151 | |
Walgreens #6411 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11951 N 1st Ave, Oro Valley, Arizona 85737 Phone: (520) 531-8964 | |
Walmart Pharmacy 10-4264 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7951 N Oracle Rd, Oro Valley, Arizona 85704 Phone: (520) 469-9563 | |
Walmart Pharmacy 10-3379 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2150 E Tangerine Rd, Oro Valley, Arizona 85755 Phone: (520) 544-2668 |